SeaTown Holdings’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

SeaTown Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-579,022	Closed	-$9.08M	–	75
2019 Q1	$9.08M	Buy	+579,022	New	+$10.2M	1.07%	39
2017 Q1	–	Sell	-231,500	Closed	-$8.39M	–	52
2016 Q4	$8.39M	Buy	+231,500	New	+$9.24M	1.93%	20
2014 Q1	–	Sell	-384,016	Closed	-$15.4M	–	22
2013 Q4	$15.4M	Buy	384,016 +259,016	+207%	+$10.2M	5.6%	7
2013 Q3	$4.78M	Buy	+125,000	New	+$4.88M	1.81%	11

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SeaTown Holdings's TEVA Position: Q2 2019 in Review

SeaTown Holdings sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 579,022 shares — an estimated $9.08M sold.

SeaTown Holdings first reported a position in TEVA in Q3 2013 and held it in 4 quarters. The position peaked at $15.4M in Q4 2013. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

SeaTown Holdings reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
SeaTown Holdings sold 579,022 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $9.08M.
SeaTown Holdings first reported a position in Teva Pharmaceutical Industries Limited in Q3 2013 and held it in 4 quarters.
SeaTown Holdings's Teva Pharmaceutical Industries Limited position peaked at $15.4M in Q4 2013.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on SeaTown Holdings's 13F filing for Q2 2019, filed 1 Aug 2019.